Characterization of insulin degrading enzyme and other amyloid-β degrading proteases in human serum: A role in alzheimer's disease?

Journal of Alzheimer's Disease

Volumn 29, Issue 2, 2012, Pages 329-340

  Liu, Zhiheng ^a,e   Zhu, Haihao ^a   Fang, Guang Guang ^a,e   Walsh, Kathryn ^a   Mwamburi, Mkaya ^c   Wolozin, Benjamin ^a,b   Abdul Hay, Samer O ^d   Ikezu, Tsuneya ^a,b   Leissring, Malcolm A ^d   Qiu, Wei Qiao ^a,b  

^a BOSTON UNIVERSITY   (United States)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d MAYO CLINIC   (United States)

^e SECOND PEOPLE S HOSPITAL OF SHENZHEN   (China)

Author keywords

Alzheimer's disease; angiotensin converting enzyme; A degradation; insulin degrading enzyme; protease; serum

Indexed keywords

AMYLIN; AMYLOID BETA PROTEIN; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; EDETIC ACID; INSULIN; INSULINASE; LISINOPRIL; PEPTIDE; PROTEINASE; SUBSTRATE V; UNCLASSIFIED DRUG;

AGED; ALZHEIMER DISEASE; AMINO ACID SEQUENCE; ARTICLE; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; DISEASE COURSE; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME ASSAY; ENZYME BLOOD LEVEL; ENZYME SUBSTRATE; FEMALE; HUMAN; INSULIN DEGRADATION; MAJOR CLINICAL STUDY; MALE; MILD COGNITIVE IMPAIRMENT; MULTIINFARCT DEMENTIA; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN DEGRADATION;

EID: 84859394857     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-2011-111472     Document Type: Article

References (39)

1. Selkoe DJ (2008) Biochemistry and molecular biology of amyloid beta-protein and the mechanism of Alzheimer's disease. Handb Clin Neurol 89, 245-260.
2. Mawuenyega KG, Sigurdson W, Ovod V, Munsell L, Kasten T, Morris JC, Yarasheski KE, Bateman RJ (2011) Decreased clearance of CNS beta-amyloid in Alzheimer's disease. Science 330, 1774.
3. Deane R, Wu Z, Sagare A, Davis J, Du Yan S, Hamm K, Xu F, Parisi M, LaRue B, Hu HW, Spijkers P, Guo H, Song X, Lent-ing PJ, Van Nostrand WE, Zlokovic BV (2004) LRP/amyloid beta-peptide interaction mediates differential brain efflux of Abeta isoforms. Neuron 43, 333-344. (Pubitemid 39061126)
4. Graff-Radford NR, Crook JE, Lucas J, Boeve BF, Knopman DS, Ivnik RJ, Smith GE, Younkin LH, Petersen RC, Younkin SG (2007) Association of low plasma Abeta42/Abeta40 ratios with increased imminent risk for mild cognitive impairment and Alzheimer disease. Arch Neurol 64, 354-362. (Pubitemid 46425689)
5. Liu Y, Studzinski C, Beckett T, Murphy MP, Klein RL, Hersh LB (2010) Circulating neprilysin clears brain amyloid. Mol Cell Neurosci 45, 101-107.
6. Kurochkin IV, Goto S (1994) Alzheimer's beta-amyloid pep-tide specifically interacts with and is degraded by insulin degrading enzyme. FEBS Lett 345, 33-37.
7. McDermott JR, Gibson AM (1997) Neurochem Res22, 49-56.
8. Qiu WQ et al. (1998) Degradation of Alzheimer's beta-amyloid protein by human and rat brain peptidases: Involvement of insulin-degrading enzyme. J Biol Chem 273, 32730-32738.
9. Shen Y, Joachimiak A, Rosner MR, Tang WJ (2006) Structures of human insulin-degrading enzyme reveal a new substrate recognition mechanism. Nature 443, 870-874. (Pubitemid 44622699)
10. Hu J, Igarashi A, Kamata M, Nakagawa H (2001) Angiotensin-converting enzyme degrades Alzheimer amyloid beta-peptide (A beta); retards A beta aggregation, deposition, fibril formation; and inhibits cytotoxicity. J Biol Chem 276, 47863-47868.
11. Hemming ML, Selkoe DJ (2005) Insulin-degrading enzyme regulates extracellular levels of amyloid beta-protein by degradation. J Biol Chem 280, 37644-37650.
12. Iwata N, Tsubuki S, Takaki Y, Watanabe K, Sekiguchi M, Hosoki E, Kawashima-Morishima M, Lee HJ, Hama E, Sekine-Aizawa Y, Saido TC (2000) Identification ofthe major Abeta1-42-degrading catabolicpathway in brain parenchyma: Suppression leads to biochemical and pathological deposition. Nat Med 6, 143-150. (Pubitemid 30082357)
13. Gao W, Eisenhauer PB, Conn K, Lynch JA, Wells JM, Ullman MD, McKee A, Thatte HS, Fine RE (2004) Insulin degrading enzyme is expressed in the human cerebrovascular endothe-lium and in cultured human cerebrovascular endothelial cells. Neurosci Lett 371, 6-11. (Pubitemid 39410505)
14. Vekrellis K, Ye Z, Qiu WQ, Walsh D, Hartley D, Chesneau V, Rosner MR, Selkoe DJ (2000) Neurons regulate extracellular levels of amyloid beta-protein via proteolysis by insulin-degrading enzyme. J Neurosci 20, 1657-1665. (Pubitemid 30220363)
15. Ralat LA, Ren M, Schilling AB, Tang WJ (2009) Protective role of Cys-178 against the inactivation and oligomerization of human insulin-degrading enzyme by oxidation and nitro-sylation. J Biol Chem 284, 34005-34018.
16. Qiu WQ, Dean M, Liu T, George L, Gann M, Cohen J, Bruce ML (2010) Physical and mental health of homebound older adults: Anoverlooked population. J Am Geriatr Soc58, 2423-2428.
17. Lan X, Xu J, Kiyota T, Peng H, Zheng JC, Ikezu T (2011) HIV-1 reduces Abeta-degrading enzymatic activities in primary human mononuclear phagocytes. J Immunol 186, 6925-6932.
18. Delledonne A, Kouri N, Reinstatler L, Sahara T, Li L, Zhao J, Dickson DW, Ertekin-Taner N, Leissring MA (2009) Development of monoclonal antibodies and quantitative ELISAs targeting insulin-degrading enzyme. Mol Neurodegener 4, 39.
19. Scott TM, Peter I, Tucker KL, Arsenault L, Bergethon P, Bhadelia R, Buell J, Collins L, Dashe JF, Griffith J, Hibberd P, Leins D, Liu T, Ordovas JM, Patz S, Price LL, Qiu WQ, Sar-nak M, Selhub J, Smaldone L, Wagner C, Wang L, Weiner D, Yee J, Rosenberg I, Folstein M (2006) The Nutrition, Aging, and Memory in Elders (NAME) study: Design and methods for a study of micronutrients and cognitive function in a homebound elderly population. Int J Geriatr Psychiatry 21, 519-528. (Pubitemid 44043752)
20. Qiu WQ, Sun X, Selkoe DJ, Mwamburi DM, Huang T, Bhadela R, Bergethon P, Scott TM, Summergrad P, Wang L, Rosenberg I, Folstein M (2007) Depression is associated with low plasma Abeta42 independently of cardiovascular disease in the homebound elderly. Int J Geriatr Psychiatry 22, 536-542. (Pubitemid 46951751)
21. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984) Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 34 (7), 939-944. (Pubitemid 14076461)
22. RománGC, Tatemichi TK, Erkinjuntti T, Cummings JL, Mas-deu JC, Garcia JH, Amaducci L, Orgogozo JM, Brun A, Hofman A, et al. (1993) Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology 43 (2), 250-260. (Pubitemid 23060253)
23. Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E (1999) Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of department of health and human services task force on Alzheimer's disease. Arch Neurol 56, 303-308.
24. Scott TM, Tucker KL, Bhadelia A, Benjamin B, Patz S, Bhadelia R, Liebson E, Price LL, Griffith J, Rosenberg I, Folstein MF (2004) Homocysteine and B vitamins relate to brain volume and white-matter changes in geriatric patients with psychiatric disorders. Am J Geriatr Psychiatry 12, 631-638. (Pubitemid 41031065)
25. Leissring MA, Farris W, Chang AY, Walsh DM, Wu X, Sun X, Frosch MP, Selkoe DJ (2003) Enhanced proteolysis of beta-amyloid in APP transgenic mice prevents plaque formation, secondary pathology, and premature death. Neuron 40, 1087-1093. (Pubitemid 38032786)
26. Zhao J, Li L, Leissring MA (2009) Insulin-degrading enzyme is exported via an unconventional protein secretion pathway. Mol Neurodegener 4, 4.
27. Tamboli IY, Barth E, Christian L, Siepmann M, Kumar S, Singh S, Tolksdorf K, Heneka MT, Lutjohann D, Wunderlich P, Walter J (2010) Statins promote the degradation ofextracel-lular amyloid {beta}-peptide by microglia via stimulation of exosome-associated insulin-degrading enzyme (IDE) secretion. J Biol Chem 285, 37405-37414.
28. Jiang Q, Lee CY, Mandrekar S, Wilkinson B, Cramer P, Zelcer N, Mann K, Lamb B, Willson TM, Collins JL, Richardson JC, Smith JD, Comery TA, Riddell D, Holtzman DM, Tontonoz P, Landreth GE (2008) ApoE promotes the proteolytic degradation of Abeta. Neuron 58, 681-693. (Pubitemid 351778466)
29. Zou K, Maeda T, Watanabe A, Liu J, Liu S, Oba R, Satoh Y, Komano H, Michikawa M (2009) Abeta42-to-Abeta40-and angiotensin-converting activities in different domains of angiotensin-converting enzyme. J Biol Chem 284, 31914-31920.
30. Vardy ER, Rice PJ, Bowie PC, Holmes JD, Catto AJ, Hooper NM (2009) Plasma angiotensin-converting enzyme in Alzheimer's disease. J Alzheimers Dis 16, 609-618.
31. Akatsu H, Ogawa N, Kanesaka T, Hori A, Yamamoto T, Mat-sukawa N, Michikawa M (2011) Higher activity of peripheral blood angiotensin-converting enzyme is associated with later-onset of Alzheimer's disease. J Neurol Sci 300, 67-73.
32. Casal JA, Robles A, Tutor JC (2003) Serum markers of mono-cyte/macrophage activation in patients with Alzheimer's disease and other types of dementia. Clin Biochem 36, 553-556. (Pubitemid 37244018)
33. Zou K, Yamaguchi H, Akatsu H, Sakamoto T, Ko M, Mizoguchi K, Gong JS, Yu W, Yamamoto T, Kosaka K, Yanagisawa K, Michikawa M (2007) Angiotensin-converting enzyme converts amyloid beta-protein 1-42 (Abeta (1-42)) to Abeta (1-40), and its inhibition enhances brain Abeta deposition. J Neurosci 27, 8628-8635. (Pubitemid 47254272)
34. Fan J, Donkin J, Wellington C (2009) Greasing the wheels of Abeta clearance in Alzheimer's disease: The role of lipids and apolipoprotein E. Biofactors 35, 239-248.
35. Miners JS, Kehoe PG, Love S (2008) Immunocapture-based fluorometric assay for the measurement of insulin-degrading enzyme activity in brain tissue homogenates. J Neurosci Methods 169, 177-181.
36. Bertram L, McQueen MB, Mullin K, Blacker D, Tanzi RE (2007) Systematic meta-analyses of Alzheimer disease genetic association studies: The AlzGene database. Nat Genet 39, 17-23. (Pubitemid 46026496)
37. Ferrari R, Guardigli G, Ceconi C (2010) Secondaryprevention of CAD with ACE inhibitors: A struggle between life and death of the endothelium. Cardiovasc Drugs Ther 24, 331-339.
38. Lynch JA, George AM, Eisenhauer PB, Conn K, Gao W, Car-reras I, Wells JM, McKee A, Ullman MD, Fine RE (2006) Insulin degrading enzyme is localized predominantly at the cell surface of polarized and unpolarized human cerebrovas-cular endothelial cell cultures. J Neurosci Res 83, 1262-1270. (Pubitemid 43668009)
39. Hiltunen M, Makinen P, Peraniemi S, Sivenius J, van Groen T, Soininen H, Jolkkonen J (2009) Focal cerebral ischemia in rats alters APP processing and expression of Abeta peptide degrading enzymes in the thalamus. Neurobiol Dis 35, 103-113.